2-[[2-[[2-[[[1-[6-amino-2-[(2,6-diamino-1-oxohexyl)amino]-1-oxohexyl]-2-pyrrolidinyl]-oxomethyl]amino]-3-(1H-indol-3-yl)-1-oxopropyl]amino]-4,4-dimethyl-1-oxopentyl]amino]-4-methylpentanoic acid ethylester

Term ID

CHEBI:125458

Synonyms

Definition

References

LINCS:LSM-36950

Ontology

ChEBI ( EBI )

Relationships

is a type of: peptide

peptide Show first 5 Terms

Phenotype

Phenotype resulting from 2-[[2-[[2-[[[1-[6-amino-2-[(2,6-diamino-1-oxohexyl)amino]-1-oxohexyl]-2-pyrrolidinyl]-oxomethyl]amino]-3-(1H-indol-3-yl)-1-oxopropyl]amino]-4,4-dimethyl-1-oxopentyl]amino]-4-methylpentanoic acid ethylester

Phenotype where environments contain 2-[[2-[[2-[[[1-[6-amino-2-[(2,6-diamino-1-oxohexyl)amino]-1-oxohexyl]-2-pyrrolidinyl]-oxomethyl]amino]-3-(1H-indol-3-yl)-1-oxopropyl]amino]-4,4-dimethyl-1-oxopentyl]amino]-4-methylpentanoic acid ethylester

Phenotype modified by environments containing 2-[[2-[[2-[[[1-[6-amino-2-[(2,6-diamino-1-oxohexyl)amino]-1-oxohexyl]-2-pyrrolidinyl]-oxomethyl]amino]-3-(1H-indol-3-yl)-1-oxopropyl]amino]-4,4-dimethyl-1-oxopentyl]amino]-4-methylpentanoic acid ethylester

Phenotype affecting 2-[[2-[[2-[[[1-[6-amino-2-[(2,6-diamino-1-oxohexyl)amino]-1-oxohexyl]-2-pyrrolidinyl]-oxomethyl]amino]-3-(1H-indol-3-yl)-1-oxopropyl]amino]-4,4-dimethyl-1-oxopentyl]amino]-4-methylpentanoic acid ethylester

Human Disease Model